|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5804178A
(en)
|
1986-11-20 |
1998-09-08 |
Massachusetts Institute Of Technology |
Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5912017A
(en)
*
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US6130082A
(en)
|
1988-05-05 |
2000-10-10 |
American Cyanamid Company |
Recombinant flagellin vaccines
|
|
US5180806A
(en)
*
|
1988-05-16 |
1993-01-19 |
The Scripps Research Institute |
Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
GB9113809D0
(en)
*
|
1991-06-26 |
1991-08-14 |
Cancer Res Campaign Tech |
Papillomavirus l2 protein
|
|
CA2138997C
(en)
*
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
US6337070B1
(en)
*
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
DK0678034T3
(da)
*
|
1993-01-11 |
1999-11-08 |
Dana Farber Cancer Inst Inc |
Induktion af cytotoksiske T-lymfocytreaktioner
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US5543158A
(en)
*
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US6485729B1
(en)
*
|
1993-09-13 |
2002-11-26 |
Protein Sciences Corporation |
Neuraminidase-supplemented compositions
|
|
AUPM358894A0
(en)
*
|
1994-01-31 |
1994-02-24 |
Csl Limited |
Modified papilloma virus l2 protein and vlps formed therefrom
|
|
US5693325A
(en)
*
|
1994-03-15 |
1997-12-02 |
Molecumetics, Ltd. |
Peptide vaccines and methods relating thereto
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
GB9420146D0
(en)
*
|
1994-10-06 |
1994-11-23 |
Cancer Res Campaign Tech |
Papillomavirus vaccine
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
US5866132A
(en)
*
|
1995-06-07 |
1999-02-02 |
Alberta Research Council |
Immunogenic oligosaccharide compositions
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
US6946133B1
(en)
*
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
|
JP2000515741A
(ja)
*
|
1996-07-17 |
2000-11-28 |
アメリカ合衆国 |
感染性パピローマウイルス偽ウイルス粒子
|
|
EP0917570A2
(en)
*
|
1996-08-05 |
1999-05-26 |
The President And Fellows Of Harvard College |
Mhc binding peptide oligomers and methods of use
|
|
US6368598B1
(en)
*
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
IL129319A0
(en)
|
1996-10-25 |
2000-02-17 |
Minnesota Mining & Mfg |
Immune response modifier compounds for treatment of TH2 mediated and related diseases
|
|
US6211159B1
(en)
|
1997-04-11 |
2001-04-03 |
University Of Toronto |
Flagellin gene, FlaC of campylobacter
|
|
US6060082A
(en)
*
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
CA2302779C
(en)
*
|
1997-09-16 |
2010-02-02 |
Oregon Health Sciences University |
Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
|
|
DE69817393T2
(de)
|
1997-11-28 |
2004-06-17 |
Sumitomo Pharmaceuticals Co., Ltd. |
Neue heterozyklische verbindungen
|
|
US6254890B1
(en)
*
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
US6197229B1
(en)
*
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
GB9808932D0
(en)
*
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
|
US6534482B1
(en)
*
|
1998-05-13 |
2003-03-18 |
Epimmune, Inc. |
Expression vectors for stimulating an immune response and methods of using the same
|
|
EP1080370A4
(en)
*
|
1998-05-29 |
2003-07-30 |
Epimmune Inc |
IDENTIFICATION OF RESILIENT DR EPITOPES LARGELY REACTIVE
|
|
EP1388586A3
(en)
*
|
1998-05-29 |
2004-05-26 |
Epimmune Inc. |
Identification of broadly reactive DR restricted epitopes
|
|
US6306640B1
(en)
*
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
|
SK4272001A3
(en)
*
|
1998-10-05 |
2003-02-04 |
Pharmexa As |
Methods for therapeutic vaccination
|
|
KR100629028B1
(ko)
*
|
1998-10-16 |
2006-09-26 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
애쥬번트 시스템 및 백신
|
|
US6232082B1
(en)
*
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
PT1187629E
(pt)
*
|
1999-04-19 |
2005-02-28 |
Glaxosmithkline Biolog Sa |
Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
|
|
US7238368B2
(en)
*
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
ATE340592T1
(de)
*
|
1999-04-23 |
2006-10-15 |
Alza Corp |
Konjugate enthaltend eine spaltbare bindung zur anwendung in einem liposom
|
|
US6800296B1
(en)
*
|
1999-05-19 |
2004-10-05 |
Massachusetts Institute Of Technology |
Modification of surfaces using biological recognition events
|
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
US20020165176A1
(en)
*
|
2000-05-01 |
2002-11-07 |
Haynes Joel R. |
Nucleic acid immunization
|
|
CA2407897A1
(en)
*
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
US7192725B2
(en)
|
2000-05-19 |
2007-03-20 |
University Of Toronto |
Flagellin gene, flaC of Campylobacter
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US20030175950A1
(en)
*
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
EP3006043B1
(en)
|
2002-04-04 |
2019-05-29 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
FR2840499B1
(fr)
*
|
2002-05-30 |
2004-12-10 |
Cit Alcatel |
Procede et dispositif de controle d'acces a un reseau local de communications sans fil
|
|
US20060189554A1
(en)
*
|
2002-09-24 |
2006-08-24 |
Russell Mumper |
Nanoparticle-Based vaccine delivery system containing adjuvant
|
|
AU2003285932A1
(en)
*
|
2002-10-23 |
2004-05-13 |
Glaxosmithkline Biologicals S.A. |
Methods for vaccinating against malaria
|
|
EP1581904A2
(en)
*
|
2003-01-08 |
2005-10-05 |
Xencor, Inc. |
Novel proteins with altered immunogenicity
|
|
DE602004008582T2
(de)
*
|
2003-02-17 |
2008-05-21 |
Peter Burkhard |
Peptidische nanoteilchen als arzneimittelabgabe- und antigen-display-systeme
|
|
US7727969B2
(en)
*
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
EP1651258B1
(en)
*
|
2003-07-30 |
2014-03-19 |
Vaccine Research Institute of San Diego |
Hepatitis virus core proteins as vaccine platforms and methods of use thereof
|
|
US20050137156A1
(en)
*
|
2003-08-09 |
2005-06-23 |
Johnston Stephen A. |
Methods and compositions for generating an immune response
|
|
DE10347710B4
(de)
*
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
US20080160089A1
(en)
*
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
JP2007512355A
(ja)
*
|
2003-11-21 |
2007-05-17 |
アルザ コーポレイション |
開裂性のｐｅｇで表面修飾されたリポソーム−ｄｎａ複合体で媒介される遺伝子送達
|
|
MXPA06006738A
(es)
|
2003-12-19 |
2006-08-31 |
Univ North Carolina |
Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion.
|
|
JP2007526253A
(ja)
|
2004-02-19 |
2007-09-13 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
免疫刺激性ウイルスｒｎａオリゴヌクレオチド
|
|
CA2566506A1
(en)
*
|
2004-06-01 |
2005-12-15 |
Innogenetics N.V. |
Peptides for inducing a ctl and/or htl response to hepatitis c virus
|
|
WO2006080951A2
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US20080206270A1
(en)
*
|
2004-07-08 |
2008-08-28 |
Minev Boris R |
Enhancing Class I Antigen Presentation With Synthetic Sequences
|
|
US8017151B2
(en)
*
|
2004-09-07 |
2011-09-13 |
Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center |
Amphiphilic polymer-protein conjugates and methods of use thereof
|
|
EP1793863B1
(en)
*
|
2004-10-01 |
2017-04-12 |
Midatech Ltd. |
Nanoparticles comprising antigens and adjuvants capable of stimulating t helper cells
|
|
WO2006042333A2
(en)
*
|
2004-10-12 |
2006-04-20 |
Xencor, Inc. |
Prediction and assessment of immunogenicity
|
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US20090162400A1
(en)
*
|
2004-12-21 |
2009-06-25 |
Powell Thomas J |
Compositions of influenza viral proteins and methods of use thereof
|
|
WO2006083984A1
(en)
*
|
2005-02-01 |
2006-08-10 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies
|
|
AU2006241149A1
(en)
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
|
US20070178115A1
(en)
*
|
2005-08-15 |
2007-08-02 |
Tang De-Chu C |
Immunization of avians by administration of non-replicating vectored vaccines
|
|
JP4538522B2
(ja)
|
2005-11-25 |
2010-09-08 |
コーリー ファーマシューティカル ゲーエムベーハー |
免疫刺激性オリゴリボヌクレオチド
|
|
WO2007089607A2
(en)
*
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
|
JP5630998B2
(ja)
*
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
|
EP2083857A4
(en)
*
|
2006-09-22 |
2010-03-24 |
Dana Farber Cancer Res Inc |
METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA
|
|
CN101678090B
(zh)
*
|
2007-03-07 |
2012-04-11 |
乌第有限合伙公司 |
用于预防和治疗自身免疫病的组合物和方法
|
|
JP2010523595A
(ja)
*
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
EP2468763B1
(en)
*
|
2007-05-31 |
2014-06-18 |
Academisch Ziekenhuis Leiden h.o.d.n. LUMC |
HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
|
|
US20090196915A1
(en)
*
|
2007-08-21 |
2009-08-06 |
Gary Van Nest |
Composition and methods of making and using influenza proteins
|
|
JP2011500569A
(ja)
*
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
|
CA2713879C
(en)
*
|
2008-02-01 |
2020-01-07 |
Alpha-O Peptides Ag |
Self-assembling peptide nanoparticles useful as vaccines
|
|
ES2637812T3
(es)
*
|
2008-02-14 |
2017-10-17 |
Life Sciences Research Partners Vzw |
Inmunoterapia dirigida a patógenos intracelulares
|
|
WO2009108807A1
(en)
*
|
2008-02-26 |
2009-09-03 |
The Regents Of The University Of California |
Glycopeptides and methods of making and using them
|
|
JP2012524780A
(ja)
*
|
2009-04-21 |
2012-10-18 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
Ｔｈ１バイアス応答をもたらす免疫ナノ治療薬（Ｉｍｍｕｎｏｎａｎｏｔｈｅｒａｐｅｕｔｉｃｓ）
|
|
BRPI1012036A2
(pt)
*
|
2009-05-27 |
2017-10-10 |
Selecta Biosciences Inc |
nanocarreadores que possuem componentes com diferentes taxas de liberação
|
|
ES2641892T3
(es)
*
|
2009-08-26 |
2017-11-14 |
Selecta Biosciences, Inc. |
Composiciones que inducen la ayuda de las células T
|
|
WO2011085231A2
(en)
*
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
US20110262491A1
(en)
*
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
CA2798739A1
(en)
*
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
WO2012024621A2
(en)
*
|
2010-08-20 |
2012-02-23 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
|
|
JP2013538211A
(ja)
*
|
2010-08-23 |
2013-10-10 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
抗原に対する免疫反応を誘発する標的マルチエピトープ剤形
|
|
EA201390660A1
(ru)
*
|
2010-11-05 |
2013-11-29 |
Селекта Байосайенсиз, Инк. |
Модифицированные никотиновые соединения и связанные способы
|
|
US20120171229A1
(en)
*
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
MX366228B
(es)
*
|
2011-03-25 |
2019-07-03 |
Selecta Biosciences Inc |
Nanoportadores sinteticos de liberacion mediada por osmosis.
|
|
MX374963B
(es)
*
|
2011-04-29 |
2025-03-06 |
Selecta Biosciences Inc |
Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
|
|
KR20140050698A
(ko)
*
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
WO2013036301A1
(en)
*
|
2011-09-06 |
2013-03-14 |
Selecta Biosciences, Inc. |
Induced tolerogenic dendritic cells for inducing regulatory b cells
|